Literature DB >> 4517840

Induction of leukemia by 131-I treatment of thyroid carcinoma.

H Brincker, H S Hansen, A P Andersen.   

Abstract

The records of 194 patients with thyroid carcinoma treated with (131)I, representing all cases thus treated in Denmark from 1948 to 1972, were reviewed. Two cases of myeloid leukaemia were found compared with 0·097 expected cases of non-lymphocytic leukaemia (0·05 > P > 0·01). In 5 series of (131)I treated thyroid carcinomata, 10 cases of myeloid leukaemia occurred in a total of 487 patients, corresponding to a frequency of leukaemia of about 2%. These findings appear to show that (131)I treatment of thyroid carcinoma is associated with a certain risk of development of leukaemia. This risk must be considered when treatment of localized thyroid carcinoma is planned.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4517840      PMCID： PMC2008977          DOI： 10.1038/bjc.1973.142

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  6 in total

1.  Occurrence of myeloid leukemia in patients with metastatic thyroid carcinoma following prolonged massive radioiodine therapy.

Authors:  S M SEIDLIN; E SIEGEL; S MELAMED; A A YALOW
Journal:  Bull N Y Acad Med       Date:  1955-05

2.  Acute leukaemia following x-ray and radioiodine treatment of thyroid carcinoma.

Authors:  P S BLOM; A QUERIDO; C H LEEKSMA
Journal:  Br J Radiol       Date:  1955-03       Impact factor: 3.039

3.  Chronic myelogenous leukemia following I-131 therapy for metastatic thyroid carcinoma. Report of a case and some considerations on the etiologic factors.

Authors:  A OZARDA; U ERGIN; M A BENDER
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1961-05

4.  [Cancer of the thyroid treated with radioactive iodine; termination by acute leukemia after an important amelioration].

Authors:  J DELARUE; M TUBIANA; J DUTREIX
Journal:  Bull Assoc Fr Etud Cancer       Date:  1953

5.  Pathogenesis of radiation-related leukaemia and lymphoma. Speculations based primarily on experience of Hiroshima and Nagasaki.

Authors:  R E Anderson; H Nishiyama; Y Ii; K Ishida; N Okabe
Journal:  Lancet       Date:  1972-05-13       Impact factor: 79.321

6.  Irradiation in the epidemiology of leukemia among adults.

Authors:  R Gibson; S Graham; A Lilienfeld; L Schuman; J E Dowd; M L Levin
Journal:  J Natl Cancer Inst       Date:  1972-02       Impact factor: 13.506
  6 in total
  8 in total

1.  Cancer in iodine-131 exposed patients.

Authors:  P Hall; L E Holm
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

2.  Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.

Authors:  H Hundeshagen
Journal:  Eur J Nucl Med       Date:  1983

Review 3.  The clinician and the thyroid.

Authors:  H J Biersack; A Hotze
Journal:  Eur J Nucl Med       Date:  1991

Review 4.  Drug therapy alternatives in the treatment of thyroid cancer.

Authors:  M J O'Doherty; A J Coakley
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 5.  Radionuclide therapy of the thyroid.

Authors:  S E Clarke
Journal:  Eur J Nucl Med       Date:  1991

6.  Leukaemias and cancers following iodine-131 administration for thyroid cancer.

Authors:  F de Vathaire; M Schlumberger; M J Delisle; C Francese; C Challeton; E de la Genardiére; F Meunier; C Parmentier; C Hill; H Sancho-Garnier
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number?

Authors:  Ajit S Shinto; K K Kamaleshwaran; Deepu K Shibu; K Vyshak; Joppy Antony
Journal:  World J Nucl Med       Date:  2013-05

8.  Cancer risks in thyroid cancer patients.

Authors:  P Hall; L E Holm; G Lundell; G Bjelkengren; L G Larsson; S Lindberg; J Tennvall; H Wicklund; J D Boice
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.